跳至主要内容
临床试验/NCT05471388
NCT05471388Unknown不适用

Assessment of Serum Asprosin Level in Male Patients With Acne Vulgaris

Sohag University1 个研究点 分布在 1 个国家目标入组 72 人开始时间: 2022年7月18日最近更新:
适应症

试验速览

阶段
不适用
入组人数
72
试验地点
1
主要终点
Assess serum asprosin level in male patients with acne vulgaris.

研究概览

简要总结

Subject of interest is to evaluate serum level of asprosin in male patients with acne vulgaris, demonstrate the relation between acne vulgaris severity and level of asprosin in these patients & the relation between metabolic syndrome in acne vulgaris and level of asprosin.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Acne vulgaris male patients (>18 years) will be included.

排除标准

  • Age <18 years.
  • Patients with other inflammatory skin disorders.
  • Patients with associated systemic diseases.
  • Current or previous treatment with isotretinoin in the last 3 month ,anti-inflammatory drugs, systemic antibiotics, androgen or anti androgen therapy, and steroid therapy).
  • Patients known on treatment of diabetes, hypertension and dyslipidemia.
  • Athletes.
  • Patient refusal.

结局指标

主要结局

Assess serum asprosin level in male patients with acne vulgaris.

时间窗: 6 months

Assess serum asprosin level in male patients with acne vulgaris.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Esraa Abdel-Azeem Hamoda

resident doctor at Dematology, Venereology and Andrology department at Sohag University Hospital

Sohag University

研究点 (1)

Loading locations...

相似试验